Does fatty liver make your poo stink? This is a common concern for people diagnosed with non-alcoholic fatty liver disease (NAFLD), which affects approximately one in three UK adults. Whilst simple fatty liver disease does not directly cause foul-smelling stools, understanding the relationship between liver health and digestive function is important. Changes in stool odour are far more commonly caused by dietary factors, gastrointestinal infections, or malabsorption disorders rather than uncomplicated fatty liver. However, advanced liver disease with impaired bile flow may occasionally affect fat digestion and stool characteristics. This article explores the connection between fatty liver and digestive symptoms, when to seek medical advice, and how to manage both liver and digestive health effectively.

Understanding Fatty Liver Disease and Digestive Symptoms

Fatty liver disease, medically termed hepatic steatosis, occurs when excess fat accumulates in liver cells. In the UK, non-alcoholic fatty liver disease (NAFLD) affects approximately one in three adults, making it the most common liver condition. The disease exists on a spectrum, ranging from simple steatosis (fat accumulation without inflammation) to non-alcoholic steatohepatitis (NASH), which involves inflammation and potential liver damage. (Note: some guidelines now use the term metabolic dysfunction-associated steatotic liver disease [MASLD], though NAFLD remains widely used in UK clinical practice.)

The liver plays a crucial role in digestion, producing bile that helps break down fats and absorb fat-soluble vitamins. It also processes nutrients absorbed from the intestines, metabolises medications, and removes toxins from the bloodstream. In simple steatosis, liver function is typically preserved. However, when the condition progresses to NASH with inflammation, or to advanced fibrosis or cirrhosis, these functions may become compromised, potentially affecting various aspects of digestion and metabolism.

Many people with fatty liver disease experience no symptoms, particularly in the early stages. However, as the condition progresses, some individuals may notice digestive changes alongside other symptoms such as fatigue or discomfort in the upper right abdomen. Unexplained weight loss is not typical of uncomplicated NAFLD and should prompt urgent GP review, as it may indicate advanced liver disease or another serious condition. Understanding the relationship between liver health and digestive function is important for recognising when symptoms warrant medical attention.

Risk factors for NAFLD include obesity, type 2 diabetes, high cholesterol, metabolic syndrome, and insulin resistance. The condition is closely linked to lifestyle factors, and according to NICE guideline NG49 (NAFLD: assessment and management), management focuses primarily on addressing underlying metabolic risk factors through dietary modification, weight loss, and increased physical activity.

Can Fatty Liver Cause Changes in Stool Odour?

Whilst fatty liver disease itself does not directly cause foul-smelling stools, there is no established clinical evidence linking simple hepatic steatosis to changes in stool odour. However, when liver disease progresses to advanced stages with significant impairment of bile flow—a condition called cholestasis—indirect effects on digestion may occur that could potentially influence stool characteristics.

The mechanism by which advanced liver dysfunction might affect stools involves bile production and secretion. Bile acids, produced by the liver and stored in the gallbladder, are essential for fat digestion and absorption. Cholestasis, which may occur in advanced liver disease, cholestatic liver conditions, or biliary obstruction, can lead to malabsorption of dietary fats, resulting in steatorrhoea (fatty stools) that may appear pale, greasy, float in the toilet, and have an unusually strong odour. However, this typically occurs only in cholestatic or advanced liver disease with significant fibrosis or cirrhosis, not in uncomplicated fatty liver.

It is important to note that foul-smelling stools are far more commonly caused by other factors unrelated to fatty liver disease. These include:

• Dietary factors (high-fat foods, certain vegetables such as broccoli or cabbage, spices)

• Gastrointestinal infections

• Malabsorption disorders (coeliac disease, lactose intolerance)

• Inflammatory bowel disease

• Pancreatic insufficiency

• Small intestinal bacterial overgrowth (SIBO)

• Certain medications or supplements

If you have been diagnosed with fatty liver disease and notice persistent changes in stool odour, it is more likely related to dietary habits, concurrent digestive conditions, or the metabolic factors that contribute to fatty liver rather than the liver condition itself. If you suspect a medicine or supplement may be causing digestive symptoms, discuss this with your GP or pharmacist. You can report suspected side effects from any medicine or supplement via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app.

Other Digestive Signs of Fatty Liver Disease

Whilst fatty liver disease often remains asymptomatic, some individuals may experience digestive symptoms, particularly as the condition progresses. Abdominal discomfort in the upper right quadrant is one of the more common complaints, typically described as a dull ache or feeling of fullness beneath the ribs. This occurs because the enlarged, fatty liver stretches the liver capsule, which contains pain-sensitive nerve fibres.

Bloating and feelings of fullness are frequently reported by people with NAFLD, though these symptoms are non-specific and often relate to associated conditions such as obesity, metabolic syndrome, or concurrent irritable bowel syndrome. The relationship between fatty liver and these symptoms may be indirect, mediated through shared metabolic dysfunction rather than direct liver impairment.

Some patients report nausea or loss of appetite, particularly when fatty liver progresses to NASH with inflammation or to more advanced disease. These symptoms are non-specific and may occur in various digestive conditions. Reduced bile flow due to cholestasis or advanced liver disease can impair fat digestion, though this is uncommon in uncomplicated NAFLD.

Changes in bowel habits, including occasional diarrhoea or constipation, may occur in people with fatty liver disease, but these are typically related to dietary patterns, physical inactivity, or medications rather than liver dysfunction itself. Individuals with metabolic syndrome—which frequently accompanies NAFLD—often experience various digestive complaints that may improve with lifestyle modifications.

Advanced liver disease may present with more concerning signs, including jaundice (yellowing of skin and eyes), dark urine, pale stools, easy bruising, or fluid accumulation in the abdomen (ascites). These indicate significant liver impairment requiring urgent medical assessment.

When to Seek Medical Advice About Stool Changes

Whilst occasional changes in stool odour are usually benign and related to diet, certain patterns warrant medical evaluation. You should contact your GP if you experience:

• Persistently foul-smelling stools lasting more than two to three weeks

• Pale, clay-coloured stools (suggesting bile flow problems)

• Stools that are greasy, float, or are difficult to flush (steatorrhoea)

• Dark, tar-like stools or visible blood (indicating gastrointestinal bleeding)

• Accompanying symptoms such as abdominal pain, jaundice, unexplained weight loss, or persistent nausea

• Significant changes in bowel habits lasting more than three weeks

If stool odour changes are accompanied by red-flag symptoms such as unexplained weight loss, persistent abdominal pain, rectal bleeding, or jaundice, seek GP review promptly—these may indicate conditions requiring urgent investigation.

Seek urgent medical attention (contact NHS 111 or attend A&E) if stool changes occur alongside severe abdominal pain, high fever, signs of dehydration, confusion, jaundice with severe illness, or signs of significant gastrointestinal bleeding, as these may indicate serious complications requiring immediate assessment.

If you have been diagnosed with fatty liver disease, inform your GP about any new digestive symptoms during routine monitoring appointments. According to NICE guideline NG49, patients with NAFLD should undergo regular assessment of fibrosis risk. In primary care, this typically involves calculating a FIB-4 score or NAFLD Fibrosis Score; if the result is indeterminate, an Enhanced Liver Fibrosis (ELF) blood test may be arranged. For adults with NAFLD, fibrosis risk assessment should be repeated every three years, or sooner if clinical circumstances change. New or worsening digestive symptoms may prompt additional investigations to exclude other conditions or assess for disease advancement.

Investigations your GP may arrange include:

• Blood tests (liver function tests, full blood count, inflammatory markers, ELF test)

• Stool samples (to check for infection, inflammation, or malabsorption)

• Abdominal ultrasound or transient elastography (e.g., FibroScan) to assess liver structure and stiffness

• Referral to gastroenterology or hepatology for specialist assessment

Early evaluation of concerning symptoms allows for timely diagnosis and management of both liver-related and non-liver causes of digestive changes, improving outcomes and preventing complications.

Managing Fatty Liver and Digestive Health

The cornerstone of fatty liver disease management, as recommended by NICE guideline NG49, focuses on lifestyle modification to address underlying metabolic dysfunction. Weight loss of 7–10% of body weight has been shown in clinical studies to significantly reduce liver fat and inflammation, and may also improve associated digestive symptoms. This should be achieved gradually (approximately 0.5–1 kg per week) through sustainable dietary changes and increased physical activity rather than crash dieting.

Dietary recommendations for fatty liver disease include:

• Following a balanced, Mediterranean-style diet rich in vegetables, fruits, whole grains, and lean proteins

• Reducing intake of saturated fats, refined carbohydrates, and added sugars

• Limiting processed foods and avoiding excessive fructose (found in sugary drinks and processed foods)

• Moderating portion sizes to support gradual weight loss

• Increasing dietary fibre through vegetables, fruits, and whole grains to support regular bowel movements and a healthy gut microbiome

• Staying well-hydrated with water rather than sugary or caffeinated beverages

Alcohol consumption: The UK Chief Medical Officers advise that to keep health risks from alcohol low, it is safest not to drink more than 14 units per week on a regular basis, spread over three or more days. If you have NAFLD, your GP may advise you to stay within these low-risk limits or to consider abstaining from alcohol altogether, particularly if you have advanced liver disease or other risk factors. Discuss your individual circumstances with your healthcare team.

Physical activity is equally important. The UK Chief Medical Officers and NHS recommend at least 150 minutes of moderate-intensity aerobic exercise weekly for adults. Regular activity improves insulin sensitivity, aids weight management, and directly reduces liver fat independent of weight loss. Activities such as brisk walking, swimming, or cycling are excellent choices.

Probiotic-rich foods like yoghurt or fermented vegetables may benefit digestive function, though evidence specifically for fatty liver remains limited.

Medical management may include treatment of associated conditions such as diabetes, hypertension, or high cholesterol. Lipid-lowering therapy, such as statins, should not be withheld solely because of NAFLD when clinically indicated for cardiovascular risk reduction. Currently, no medications are specifically licensed in the UK for treating NAFLD itself, though research into pharmacological therapies continues. Your GP or specialist will monitor liver health and fibrosis risk regularly using non-invasive tests and adjust management based on disease progression.

Addressing fatty liver disease through these evidence-based approaches not only improves liver health but often resolves associated digestive symptoms, enhances overall metabolic health, and reduces cardiovascular risk—the leading cause of mortality in people with NAFLD.

Frequently Asked Questions